| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3340110 | Allergologia et Immunopathologia | 2010 | 9 Pages |
Abstract
The new extensively hydrolysed casein product is safe and well tolerated by most children with ACMP. However, as with other extensive hydrolysates, some highly sensitised patients may present clinical manifestations. Controlled tolerance testing is therefore advised, under specialised medical supervision.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
M. Ibero, J. Boné, B. MartÃn, J. MartÃnez,